Evidence map›Paper›PMID 29391544›Full record

ArticleScientific reports2018

Adipocyte-specific expression of C-type natriuretic peptide suppresses lipid metabolism and adipocyte hypertrophy in adipose tissues in mice fed high-fat diet.

Cho-Rong Bae, Jun Hino, Hiroshi Hosoda, Cheol Son, Hisashi Makino, Takeshi Tokudome, Tsutomu Tomita, Kiminori Hosoda, Mikiya Miyazato, Kenji Kangawa

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. HeterozygousGenes · 2022
    Article
  7. C-type natriuretic peptide is a pivotal regulator of metabolic homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. miR-146a regulates insulin sensitivity via NPR3.Cellular and molecular life sciences : CMLS · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Cho-Rong BaeDepartment of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Jun HinoDepartment of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan. jhino@ncvc.go.jp.ORCID http://orcid.org/0000-0003-4740-8858
Hiroshi HosodaDepartments of Regenerative Medicine and Tissue Engineering, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Cheol SonDivision of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Hisashi MakinoDivision of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Takeshi TokudomeDepartment of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Tsutomu TomitaDivision of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Kiminori HosodaDivision of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Mikiya MiyazatoDepartment of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
Kenji KangawaDepartment of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan. kangawa@ncvc.go.jp.
National Cerebral and Cardiovascular Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

C-type natriuretic peptide (CNP) is expressed in diverse tissues, including adipose and endothelium, and exerts its effects by binding to and activating its receptor, guanylyl cyclase B. Natriuretic peptides regulate intracellular cGMP and phosphorylated vasodilator-stimulated phosphoprotein (VASP). We recently revealed that overexpression of CNP in endothelial cells protects against high-fat diet (HFD)-induced obesity in mice. Given that endothelial CNP affects adipose tissue during obesity, CNP in adipocytes might directly regulate adipocyte function during obesity. Therefore, to elucidate the effect of CNP in adipocytes, we assessed 3T3-L1 adipocytes and transgenic (Tg) mice that overexpressed CNP specifically in adipocytes (A-CNP). We found that CNP activates the cGMP-VASP pathway in 3T3-L1 adipocytes. Compared with Wt mice, A-CNP Tg mice showed decreases in fat weight and adipocyte hypertrophy and increases in fatty acid β-oxidation, lipolysis-related gene expression, and energy expenditure during HFD-induced obesity. These effects led to decreased levels of the macrophage marker F4/80 in the mesenteric fat pad and reduced inflammation. Furthermore, A-CNP Tg mice showed improved glucose tolerance and insulin sensitivity, which were associated with enhanced insulin-stimulated Akt phosphorylation. Our results suggest that CNP overexpression in adipocytes protects against adipocyte hypertrophy, excess lipid metabolism, inflammation, and decreased insulin sensitivity during HFD-induced obesity.

Indexed as

AdipocytesAdipose TissueAnimalsDiet, High-FatEnergy MetabolismHypertrophyInsulin ResistanceLipid MetabolismLipolysisMaleMiceMice, Inbred C57BLNatriuretic AgentsNatriuretic Peptide, C-TypeObesityNatriuretic AgentsNatriuretic Peptide, C-Type

Identifiers

PMID29391544
PMCPMC5794866
OpenAlexW2795241391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.